These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22818623)

  • 1. Plasma levels of antibodies against oxidized LDL are inherited but not associated with HDL-cholesterol level in families with early coronary heart disease.
    Paavola T; Kangas-Kontio T; Salonurmi T; Kuusisto S; Huusko T; Savolainen MJ; Kakko S
    Atherosclerosis; 2012 Sep; 224(1):123-8. PubMed ID: 22818623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidized LDL and anti-oxLDL antibody levels in peripheral atherosclerotic disease.
    Andican G; Seven A; Uncu M; Cantaşdemir M; Numan F; Burçak G
    Scand J Clin Lab Invest; 2008; 68(6):473-8. PubMed ID: 18609113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is plasma oxidized low-density lipoprotein, measured with the widely used antibody 4E6, an independent predictor of coronary heart disease among U.S. men and women?
    Wu T; Willett WC; Rifai N; Shai I; Manson JE; Rimm EB
    J Am Coll Cardiol; 2006 Sep; 48(5):973-9. PubMed ID: 16949489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to oxidized low-density lipoprotein in patients following coronary artery revascularization.
    Miller ER; Erlinger TP; Blumenthal RS; Margolis S; Allen JK
    Coron Artery Dis; 2003 Apr; 14(2):163-9. PubMed ID: 12655280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidized low-density lipoprotein autoantibodies, chronic infections, and carotid atherosclerosis in a population-based study.
    Mayr M; Kiechl S; Tsimikas S; Miller E; Sheldon J; Willeit J; Witztum JL; Xu Q
    J Am Coll Cardiol; 2006 Jun; 47(12):2436-43. PubMed ID: 16781371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autoantibodies against oxidised low density lipoproteins in patients with coronary disease].
    Maggi E; Perani G; Falaschi F; Frattoni A; Martignoni A; Finardi G; Stefano PL; Simeone F; Paolini G; DeVecchi E
    Presse Med; 1994 Jul 2-9; 23(25):1158-62. PubMed ID: 7971845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidized low-density lipoproteins, autoantibodies against oxidized low-density lipoproteins and carotid intima media thickness in a clinically healthy population.
    Chen HW; Kuo CL; Huang CS; Kuo SJ; Liu CS
    Cardiology; 2008; 110(4):252-9. PubMed ID: 18073481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
    Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A;
    Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The low-density lipoprotein (LDL)-associated PAF-acetylhydrolase activity and the extent of LDL oxidation are important determinants of the autoantibody titers against oxidized LDL in patients with coronary artery disease.
    Lourida ES; Papathanasiou AI; Goudevenos JA; Tselepis AD
    Prostaglandins Leukot Essent Fatty Acids; 2006 Aug; 75(2):117-26. PubMed ID: 16843649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to malondialdehyde-modified low-density lipoprotein in patients with angiographically confirmed coronary artery disease.
    McDowell A; Young IS; Wisdom GB
    J Pharm Pharmacol; 2002 Dec; 54(12):1651-7. PubMed ID: 12542895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis.
    Rontu R; Metso S; Jaakkola O; Nikkilä M; Jokela H; Lehtimäki T
    Clin Chem Lab Med; 2005; 43(4):357-60. PubMed ID: 15899649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High plasma immunoglobulin (Ig) A and low IgG antibody titers to oxidized low-density lipoprotein are associated with markers of glucose metabolism.
    Sämpi M; Veneskoski M; Ukkola O; Kesäniemi YA; Hörkkö S
    J Clin Endocrinol Metab; 2010 May; 95(5):2467-75. PubMed ID: 20332251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactive saliva IgA antibodies to oxidized LDL and periodontal pathogens in humans.
    Akhi R; Wang C; Kyrklund M; Kummu O; Turunen SP; Hyvärinen K; Kullaa A; Salo T; Pussinen PJ; Hörkkö S
    J Clin Periodontol; 2017 Jul; 44(7):682-691. PubMed ID: 28548243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High circulating autoantibodies against human oxidized low-density lipoprotein are related to stable and lower titers to unstable clinical situation.
    Santos AO; Fonseca FA; Fischer SM; Monteiro CM; Brandão SA; Póvoa RM; Bombig MT; Carvalho AC; Monteiro AM; Ramos E; Gidlund M; Figueiredo Neto AM; Izar MC
    Clin Chim Acta; 2009 Aug; 406(1-2):113-8. PubMed ID: 19523463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relations between autoantibodies against oxidized low-density lipoprotein, inflammation, subclinical atherosclerosis, and cardiovascular disease in rheumatoid arthritis.
    Peters MJ; van Halm VP; Nurmohamed MT; Damoiseaux J; Tervaert JW; Twisk JW; Dijkmans BA; Voskuyl AE
    J Rheumatol; 2008 Aug; 35(8):1495-9. PubMed ID: 18597411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.
    Faviou E; Vourli G; Nounopoulos C; Zachari A; Dionyssiou-Asteriou A
    Free Radic Res; 2005 Apr; 39(4):419-29. PubMed ID: 16028367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on serum oxidized low density lipoprotein and anti-oxidized competence in patient with coronary heart disease].
    Li GX; Li P
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 Sep; 35(5):690-2. PubMed ID: 15460421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HDL-C: role as a risk modifier.
    Barter P
    Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies to oxidized LDL and LDL-containing immune complexes as risk factors for coronary artery disease in diabetes mellitus.
    Lopes-Virella MF; Virella G; Orchard TJ; Koskinen S; Evans RW; Becker DJ; Forrest KY
    Clin Immunol; 1999 Feb; 90(2):165-72. PubMed ID: 10080827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.